Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers (Meningococcal Infection)”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Large-scale testing (Phase 3)Study completedNCT00384397
What this trial is testing

2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,128
Large-scale testing (Phase 3)Study completedNCT01274897
What this trial is testing

A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 450
Testing effectiveness (Phase 2)Study completedNCT01165242
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,013
Testing effectiveness (Phase 2)Study completedNCT00454909
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 873
Testing effectiveness (Phase 2)Study completedNCT00356369
What this trial is testing

Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Early research (Phase 1)UnknownNCT02878291
What this trial is testing

Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

Who this might be right for
Meningitis, Meningococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 200
Large-scale testing (Phase 3)Study completedNCT03964012
What this trial is testing

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Who this might be right for
Meningococcal Meningitis
Serum Institute of India Pvt. Ltd. 1,800
Early research (Phase 1)UnknownNCT06314880
What this trial is testing

Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli)

Who this might be right for
Healthy Volunteers
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 300
Large-scale testing (Phase 3)Study completedNCT03869866
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 290
Large-scale testing (Phase 3)Active Not RecruitingNCT07135986
What this trial is testing

Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

Who this might be right for
Meningococcal InfectionHealthy Volunteers
Sanofi 1,602
Testing effectiveness (Phase 2)Study completedNCT00126945
What this trial is testing

Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 125
Testing effectiveness (Phase 2)Study completedNCT00780806
What this trial is testing

Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

Who this might be right for
Meningitis, Meningococcal
Wyeth is now a wholly owned subsidiary of Pfizer 60
Large-scale testing (Phase 3)Study completedNCT00514904
What this trial is testing

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects

Who this might be right for
Infections, MeningococcalMeningococcal Vaccines
GlaxoSmithKline 1,504
Not applicableEnded earlyNCT03549325
What this trial is testing

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14

Who this might be right for
Meningitis, Meningococcal
University Hospital Southampton NHS Foundation Trust 21
Large-scale testing (Phase 3)Study completedNCT01641042
What this trial is testing

Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 86
Post-approval studies (Phase 4)Study completedNCT01659996
What this trial is testing

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Who this might be right for
MeningitisMeningococcal InfectionDiphtheria+3 more
Sanofi Pasteur, a Sanofi Company 1,394
Large-scale testing (Phase 3)Study completedNCT04142242
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49

Who this might be right for
Meningococcal Infection (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 471
Large-scale testing (Phase 3)Study completedNCT03632720
What this trial is testing

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 788
Large-scale testing (Phase 3)Study completedNCT02141516
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.

Who this might be right for
Meningococcal Disease
Novartis 239
Large-scale testing (Phase 3)Study completedNCT00453986
What this trial is testing

Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,352
Load More Results